Menu Search
Equities

Universal Biosensors Inc

UBI:ASX

Universal Biosensors Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.12
  • Today's Change0.00 / 0.00%
  • Shares traded181.90k
  • 1 Year change-33.10%
  • Beta1.0953
Data delayed at least 20 minutes, as of Nov 15 2024 03:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Universal Biosensors Inc grew revenues 46.58% from 4.52m to 6.63m while net income improved from a loss of 26.85m to a smaller loss of 6.74m.
Gross margin56.95%
Net profit margin-175.04%
Operating margin-227.29%
Return on assets-40.27%
Return on equity-58.81%
Return on investment-48.77%
More ▼

Cash flow in AUDView more

In 2023, cash reserves at Universal Biosensors Inc fell by 16.23m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 14.62m for operations while cash used for investing totalled 1.47m.
Cash flow per share-0.0462
Price/Cash flow per share--
Book value per share0.0701
Tangible book value per share0.0701
More ▼

Balance sheet in AUDView more

Universal Biosensors Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.23%.
Current ratio5.03
Quick ratio3.75
Total debt/total equity0.0023
Total debt/total capital0.0023
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.